AAREYDRUGS — Aarey Drugs and Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- IN₹1.89bn
- IN₹2.17bn
- IN₹3.96bn
- 40
- 50
- 77
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.42 | ||
| Price to Tang. Book | 1.42 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.4 | ||
| EV to EBITDA | 50.57 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.86% | ||
| Return on Equity | 5.22% | ||
| Operating Margin | 0.54% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 3,000.89 | 3,484.16 | 4,926.8 | 4,189.56 | 3,956.18 | n/a | n/a | 2.21% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -11.44 | +12.44 | -2.41 | -44.73 | +22.67 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxaphylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Chlorinated Solvents, Industrial Intermediates, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.
Directors
- Mihir Ghatalia CHM
- Mira Ghatalia CFO
- Preeti Rathi CCO
- Damiyanti Ghatalia DRC
- Nimit Ghatalia DRC
- Anil Mandal DRC
- Chetan Mehta NID (44)
- Lalit Tulsiani NID (57)
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- May 15th, 1990
- Public Since
- December 8th, 1993
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 28,454,303
- Address
- 107, Sahakar Bhavan, MUMBAI, 400009
- Web
- http://www.aareydrugs.com/
- Phone
- +91 2262872900
- Auditors
- Motilal & Associates
Upcoming Events for AAREYDRUGS
Q3 2025 Aarey Drugs and Pharmaceuticals Ltd Earnings Release
Similar to AAREYDRUGS
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
Ajanta Pharma
National Stock Exchange of India
FAQ
What is the Aarey Drugs and Pharmaceuticals share price?
As of Today at 19:00 UTC, shares in Aarey Drugs and Pharmaceuticals are trading at IN₹66.26. This share price information is delayed by 15 minutes.
How has the Aarey Drugs and Pharmaceuticals share price performed this year?
Shares in Aarey Drugs and Pharmaceuticals last closed at IN₹66.26 and the price had moved by +42.04% over the past 365 days. In terms of relative price strength the Aarey Drugs and Pharmaceuticals share price has outperformed the S&P BSE 100 Index by +7.38% over the past year.
What are the analyst and broker recommendations for Aarey Drugs and Pharmaceuticals?
There is no consensus recommendation for this security.
Find out moreWhat is the Aarey Drugs and Pharmaceuticals dividend yield?
Aarey Drugs and Pharmaceuticals does not currently pay a dividend.
Does Aarey Drugs and Pharmaceuticals pay a dividend?
Aarey Drugs and Pharmaceuticals does not currently pay a dividend.
When does Aarey Drugs and Pharmaceuticals next pay dividends?
Aarey Drugs and Pharmaceuticals does not currently pay a dividend.
How do I buy Aarey Drugs and Pharmaceuticals shares?
To buy shares in Aarey Drugs and Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aarey Drugs and Pharmaceuticals?
As of the previous close price of IN₹66.26, shares in Aarey Drugs and Pharmaceuticals had a market capitalisation of IN₹1.89bn.
Where are Aarey Drugs and Pharmaceuticals shares listed?
Here are the trading details for Aarey Drugs and Pharmaceuticals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: AAREYDRUGS
What kind of share is Aarey Drugs and Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum Aarey Drugs and Pharmaceuticals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aarey Drugs and Pharmaceuticals share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Aarey Drugs and Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aarey Drugs and Pharmaceuticals. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +23.19%.
As of the last closing price of IN₹66.26, shares in Aarey Drugs and Pharmaceuticals were trading +25.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aarey Drugs and Pharmaceuticals PE Ratio?
The Aarey Drugs and Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹66.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aarey Drugs and Pharmaceuticals?
Aarey Drugs and Pharmaceuticals' management team is headed by:
- Mihir Ghatalia - CHM
- Mira Ghatalia - CFO
- Preeti Rathi - CCO
- Damiyanti Ghatalia - DRC
- Nimit Ghatalia - DRC
- Anil Mandal - DRC
- Chetan Mehta - NID
- Lalit Tulsiani - NID